{"transactions":[{"id":1405636,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2024-09-17T21:54:07.000Z","date":"2024-09-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":12098,"price":84.9,"value":1027120.2,"ownership":{"direct":true},"balance_after":185074,"source":{"system":"sec-edgar","filing":"0001048477-24-000141","document":"wk-form4_1726610040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000141/wk-form4_1726610040.xml","form_type":"4"}},{"id":1405635,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2024-09-17T21:54:07.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":300,"price":68.646,"value":20593.8,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":197172,"source":{"system":"sec-edgar","filing":"0001048477-24-000141","document":"wk-form4_1726610040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000141/wk-form4_1726610040.xml","form_type":"4"}},{"id":1570139,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-20T00:46:14.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":40860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter."}],"balance_after":40860,"derivative":{"exercise_price":83.87,"exercise_date":"2025-03-15","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":40860},"source":{"system":"sec-edgar","filing":"0001048477-24-000042","document":"wk-form4_1710895563.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000042/wk-form4_1710895563.xml","form_type":"4"}},{"id":1570138,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2024-03-20T00:46:14.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":33485,"price":83.87,"value":2808386.95,"ownership":{"direct":true},"balance_after":196872,"source":{"system":"sec-edgar","filing":"0001048477-24-000042","document":"wk-form4_1710895563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000042/wk-form4_1710895563.xml","form_type":"4"}},{"id":1570137,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2024-03-20T00:46:14.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":18240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 15, 2024. Price not applicable."}],"balance_after":230357,"source":{"system":"sec-edgar","filing":"0001048477-24-000042","document":"wk-form4_1710895563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000042/wk-form4_1710895563.xml","form_type":"4"}},{"id":1589773,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2024-03-07T23:54:17.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":35341,"price":85.1814,"value":3010395.8574,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $85.01 to $85.31. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":212117,"source":{"system":"sec-edgar","filing":"0001048477-24-000034","document":"wk-form4_1709855648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000034/wk-form4_1709855648.xml","form_type":"4"}},{"id":1610634,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2024-02-29T22:10:41.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":9238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":247458,"source":{"system":"sec-edgar","filing":"0001048477-24-000020","document":"wk-form4_1709244617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000020/wk-form4_1709244617.xml","form_type":"4"}},{"id":1610633,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2024-02-29T22:10:41.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":13326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":238220,"source":{"system":"sec-edgar","filing":"0001048477-24-000020","document":"wk-form4_1709244617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000020/wk-form4_1709244617.xml","form_type":"4"}},{"id":1610632,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2024-02-29T22:10:41.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":30640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":224894,"source":{"system":"sec-edgar","filing":"0001048477-24-000020","document":"wk-form4_1709244617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000020/wk-form4_1709244617.xml","form_type":"4"}},{"id":1722384,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-12-05T21:56:58.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":17750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units granted on December 1, 2023. Price not applicable."}],"balance_after":194254,"source":{"system":"sec-edgar","filing":"0001048477-23-000049","document":"wk-form4_1701813402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000049/wk-form4_1701813402.xml","form_type":"4"}},{"id":1722383,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-12-05T21:56:58.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":317,"price":66.878,"value":21200.326,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":176504,"source":{"system":"sec-edgar","filing":"0001048477-23-000049","document":"wk-form4_1701813402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000049/wk-form4_1701813402.xml","form_type":"4"}},{"id":1810179,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-08-11T17:59:31.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":90.4259,"value":1085110.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The price actually received ranged from $90.40 to $90.515. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":176187,"source":{"system":"sec-edgar","filing":"0001048477-23-000037","document":"wk-form4_1691776761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000037/wk-form4_1691776761.xml","form_type":"4"}},{"id":1948007,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2023-03-18T01:37:27.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":38450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter."}],"balance_after":38450,"derivative":{"exercise_price":87.74,"exercise_date":"2024-03-15","expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":38450},"source":{"system":"sec-edgar","filing":"0001567619-23-005295","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005295/doc1.xml","form_type":"4"}},{"id":1948006,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-03-18T01:37:27.000Z","date":"2023-03-16","kind":"tax_withholding","acquired":false,"shares":36000,"price":93.41,"value":3362760.0,"ownership":{"direct":true},"balance_after":188187,"source":{"system":"sec-edgar","filing":"0001567619-23-005295","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005295/doc1.xml","form_type":"4"}},{"id":1948005,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-03-18T01:37:27.000Z","date":"2023-03-15","kind":"tax_withholding","acquired":false,"shares":4799,"price":87.74,"value":421064.26,"ownership":{"direct":true},"balance_after":224187,"source":{"system":"sec-edgar","filing":"0001567619-23-005295","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005295/doc1.xml","form_type":"4"}},{"id":1948004,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-03-18T01:37:27.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":16840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2023. Price not applicable."}],"balance_after":228986,"source":{"system":"sec-edgar","filing":"0001567619-23-005295","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005295/doc1.xml","form_type":"4"}},{"id":1980548,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-03-02T21:08:40.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":13392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":212146,"source":{"system":"sec-edgar","filing":"0001209191-23-014606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014606/doc4.xml","form_type":"4"}},{"id":1980547,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-03-02T21:08:40.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":18220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":198754,"source":{"system":"sec-edgar","filing":"0001209191-23-014606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014606/doc4.xml","form_type":"4"}},{"id":1980546,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-03-02T21:08:40.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":36440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":180534,"source":{"system":"sec-edgar","filing":"0001209191-23-014606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014606/doc4.xml","form_type":"4"}},{"id":2023305,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2023-02-11T02:46:35.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":341,"price":62.407,"value":21280.787,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":144094,"source":{"system":"sec-edgar","filing":"0001567619-23-002420","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923002420/doc1.xml","form_type":"5"}},{"id":2047338,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2023-01-24T16:00:34.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":7520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7520,"derivative":{"exercise_price":45.66,"expiration_date":"2033-01-20","underlying":"Common Stock","underlying_shares":7520},"source":{"system":"sec-edgar","filing":"0001214659-23-001040","document":"marketforms-58265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465923001040/marketforms-58265.xml","form_type":"4"}},{"id":2047337,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-24T16:00:34.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":4444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 100% on the anniversary of the grant date."}],"balance_after":10465,"source":{"system":"sec-edgar","filing":"0001214659-23-001040","document":"marketforms-58265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465923001040/marketforms-58265.xml","form_type":"4"}},{"id":2328549,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-03-18T01:47:02.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":35830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter."}],"balance_after":35830,"derivative":{"exercise_price":78.27,"exercise_date":"2023-03-15","expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":35830},"source":{"system":"sec-edgar","filing":"0001567619-22-007187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007187/doc1.xml","form_type":"4"}},{"id":2328548,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2022-03-18T01:47:02.000Z","date":"2022-03-16","kind":"tax_withholding","acquired":false,"shares":2259,"price":80.72,"value":182346.48,"ownership":{"direct":true},"balance_after":143753,"source":{"system":"sec-edgar","filing":"0001567619-22-007187","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007187/doc1.xml","form_type":"4"}},{"id":2328547,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2022-03-18T01:47:02.000Z","date":"2022-03-15","kind":"tax_withholding","acquired":false,"shares":12101,"price":78.27,"value":947145.27,"ownership":{"direct":true},"balance_after":146012,"source":{"system":"sec-edgar","filing":"0001567619-22-007187","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007187/doc1.xml","form_type":"4"}},{"id":2328546,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2022-03-18T01:47:02.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":38790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2022. Price not applicable."}],"balance_after":158113,"source":{"system":"sec-edgar","filing":"0001567619-22-007187","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007187/doc1.xml","form_type":"4"}},{"id":2340267,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2022-03-10T22:38:02.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":12840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return for 2019 through 2021 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule:  100% vests on March 15, 2022, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":119323,"source":{"system":"sec-edgar","filing":"0001567619-22-006718","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922006718/doc1.xml","form_type":"4"}},{"id":2397517,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2022-02-14T16:51:29.000Z","date":"2022-02-11","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021."}],"balance_after":0,"derivative":{"exercise_price":20.54,"exercise_date":"2014-09-09","expiration_date":"2024-09-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001214659-22-002681","document":"marketforms-55390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922002681/marketforms-55390.xml","form_type":"4"}},{"id":2397516,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2022-02-14T16:51:29.000Z","date":"2022-02-11","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021."}],"balance_after":0,"derivative":{"exercise_price":20.54,"exercise_date":"2017-09-09","expiration_date":"2024-09-08","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001214659-22-002681","document":"marketforms-55390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922002681/marketforms-55390.xml","form_type":"4"}},{"id":2397515,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T16:51:29.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":210,"price":106.3407,"value":22331.547,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $106.33 to $106.555.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":6021,"source":{"system":"sec-edgar","filing":"0001214659-22-002681","document":"marketforms-55390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922002681/marketforms-55390.xml","form_type":"4"}},{"id":2397514,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T16:51:29.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":8700,"price":105.7963,"value":920427.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $105.28 to $106.20.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":6231,"source":{"system":"sec-edgar","filing":"0001214659-22-002681","document":"marketforms-55390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922002681/marketforms-55390.xml","form_type":"4"}},{"id":2397513,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T16:51:29.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":2090,"price":104.7646,"value":218958.014,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $104.23 to $105.20.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":14931,"source":{"system":"sec-edgar","filing":"0001214659-22-002681","document":"marketforms-55390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922002681/marketforms-55390.xml","form_type":"4"}},{"id":2397512,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T16:51:29.000Z","date":"2022-02-11","kind":"exercise","acquired":true,"shares":5000,"price":20.54,"value":102700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021."}],"balance_after":17021,"source":{"system":"sec-edgar","filing":"0001214659-22-002681","document":"marketforms-55390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922002681/marketforms-55390.xml","form_type":"4"}},{"id":2397511,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T16:51:29.000Z","date":"2022-02-11","kind":"exercise","acquired":true,"shares":6000,"price":20.54,"value":123240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021."}],"balance_after":12021,"source":{"system":"sec-edgar","filing":"0001214659-22-002681","document":"marketforms-55390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922002681/marketforms-55390.xml","form_type":"4"}},{"id":2402331,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2022-02-12T02:29:57.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":341,"price":62.407,"value":21280.787,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":106483,"source":{"system":"sec-edgar","filing":"0001567619-22-003783","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922003783/doc1.xml","form_type":"5"}},{"id":2433500,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2022-01-18T18:21:03.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":3688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":3688,"derivative":{"exercise_price":124.31,"expiration_date":"2032-01-13","underlying":"Common Stock","underlying_shares":3688},"source":{"system":"sec-edgar","filing":"0001214659-22-000847","document":"marketforms-55081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922000847/marketforms-55081.xml","form_type":"4"}},{"id":2433499,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T18:21:03.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":2546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 100% on the anniversary of the grant date."}],"balance_after":6021,"source":{"system":"sec-edgar","filing":"0001214659-22-000847","document":"marketforms-55081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465922000847/marketforms-55081.xml","form_type":"4"}},{"id":2775242,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2021-03-24T01:12:46.000Z","date":"2021-03-22","kind":"tax_withholding","acquired":false,"shares":2454,"price":78.52,"value":192688.08,"ownership":{"direct":true},"balance_after":106142,"source":{"system":"sec-edgar","filing":"0001567619-21-006820","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006820/doc1.xml","form_type":"4"}},{"id":2783471,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2021-03-18T01:31:00.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":37710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2022 and 1/48th on the 15th day of each month thereafter."}],"balance_after":37710,"derivative":{"exercise_price":78.39,"exercise_date":"2022-03-15","expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":37710},"source":{"system":"sec-edgar","filing":"0001567619-21-006551","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006551/doc1.xml","form_type":"4"}},{"id":2783470,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2021-03-18T01:31:00.000Z","date":"2021-03-16","kind":"tax_withholding","acquired":false,"shares":2259,"price":77.21,"value":174417.39,"ownership":{"direct":true},"balance_after":108596,"source":{"system":"sec-edgar","filing":"0001567619-21-006551","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006551/doc1.xml","form_type":"4"}},{"id":2783469,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2021-03-18T01:31:00.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":7460,"price":78.39,"value":584789.4,"ownership":{"direct":true},"balance_after":110855,"source":{"system":"sec-edgar","filing":"0001567619-21-006551","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006551/doc1.xml","form_type":"4"}},{"id":2783468,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2021-03-18T01:31:00.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":15320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2021.  Price not applicable."}],"balance_after":118315,"source":{"system":"sec-edgar","filing":"0001567619-21-006551","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006551/doc1.xml","form_type":"4"}},{"id":2901867,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2021-01-20T18:16:39.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":2155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":2155,"derivative":{"exercise_price":214.47,"expiration_date":"2031-01-14","underlying":"Common Stock","underlying_shares":2155},"source":{"system":"sec-edgar","filing":"0001214659-21-000679","document":"marketforms-50978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465921000679/marketforms-50978.xml","form_type":"4"}},{"id":2901866,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T18:16:39.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 100% on the anniversary of the grant date."}],"balance_after":3475,"source":{"system":"sec-edgar","filing":"0001214659-21-000679","document":"marketforms-50978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465921000679/marketforms-50978.xml","form_type":"4"}},{"id":2942157,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."}],"balance_after":6000,"derivative":{"exercise_price":20.54,"exercise_date":"2017-09-09","expiration_date":"2024-09-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":2942156,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":40,"price":237.9,"value":9516.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":2942155,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":451,"price":237.3589,"value":107048.8639,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $236.90 to $237.84.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2040,"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":2942154,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":1821,"price":235.1916,"value":428283.9036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $234.99 to $235.50.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2491,"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":2942153,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":610,"price":234.2736,"value":142906.896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $233.93 to $234.514.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4312,"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":2942152,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":4461,"price":233.4022,"value":1041207.2142,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $232.84 to $233.76.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4922,"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":2942151,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":1399,"price":232.0056,"value":324575.8344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $231.70 to $232.625.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9383,"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":2942150,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":1218,"price":230.1875,"value":280368.375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $229.63 to $230.75.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10782,"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":2942149,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T17:37:55.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":10000,"price":20.54,"value":205400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001214659-20-010487","document":"marketforms-50648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920010487/marketforms-50648.xml","form_type":"4"}},{"id":3061653,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2020-08-11T17:36:34.000Z","date":"2020-08-10","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":20.54,"exercise_date":"2014-09-09","expiration_date":"2024-09-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001214659-20-006974","document":"marketforms-49432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920006974/marketforms-49432.xml","form_type":"4"}},{"id":3061652,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T17:36:34.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":500,"price":133.072,"value":66536.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $133.04 to $133.08.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001214659-20-006974","document":"marketforms-49432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920006974/marketforms-49432.xml","form_type":"4"}},{"id":3061651,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T17:36:34.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":5800,"price":132.3393,"value":767567.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $132.03 to $132.885.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001214659-20-006974","document":"marketforms-49432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920006974/marketforms-49432.xml","form_type":"4"}},{"id":3061650,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T17:36:34.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":1300,"price":131.0827,"value":170407.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $130.86 to $131.835.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8300,"source":{"system":"sec-edgar","filing":"0001214659-20-006974","document":"marketforms-49432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920006974/marketforms-49432.xml","form_type":"4"}},{"id":3061649,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T17:36:34.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":1000,"price":129.803,"value":129803.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $129.66 to $130.18.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9600,"source":{"system":"sec-edgar","filing":"0001214659-20-006974","document":"marketforms-49432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920006974/marketforms-49432.xml","form_type":"4"}},{"id":3061648,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T17:36:34.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":900,"price":128.5633,"value":115706.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $128.04 to $128.94.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10600,"source":{"system":"sec-edgar","filing":"0001214659-20-006974","document":"marketforms-49432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920006974/marketforms-49432.xml","form_type":"4"}},{"id":3061647,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T17:36:34.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":500,"price":127.524,"value":63762.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $126.98 to $127.89.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11500,"source":{"system":"sec-edgar","filing":"0001214659-20-006974","document":"marketforms-49432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920006974/marketforms-49432.xml","form_type":"4"}},{"id":3061646,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T17:36:34.000Z","date":"2020-08-10","kind":"exercise","acquired":true,"shares":10000,"price":20.54,"value":205400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001214659-20-006974","document":"marketforms-49432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920006974/marketforms-49432.xml","form_type":"4"}},{"id":3078113,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-07-22T21:32:09.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":49423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":49423},"source":{"system":"sec-edgar","filing":"0001567619-20-013577","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013577/doc1.xml","form_type":"4"}},{"id":3078112,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-07-22T21:32:09.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":75716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":75716},"source":{"system":"sec-edgar","filing":"0001567619-20-013577","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013577/doc1.xml","form_type":"4"}},{"id":3078111,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-07-22T21:32:09.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2017-01-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-20-013577","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013577/doc1.xml","form_type":"4"}},{"id":3078110,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-22T21:32:09.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":126389,"price":130,"value":16430570.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price.  The price actually received ranged from $130.00 to $130.04.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":102995,"source":{"system":"sec-edgar","filing":"0001567619-20-013577","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013577/doc1.xml","form_type":"4"}},{"id":3078109,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-22T21:32:09.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":49423,"price":63.1,"value":3118591.3,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."}],"balance_after":229384,"source":{"system":"sec-edgar","filing":"0001567619-20-013577","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013577/doc1.xml","form_type":"4"}},{"id":3078108,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-22T21:32:09.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":75716,"price":67.81,"value":5134301.96,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."}],"balance_after":179961,"source":{"system":"sec-edgar","filing":"0001567619-20-013577","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013577/doc1.xml","form_type":"4"}},{"id":3078107,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-22T21:32:09.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":1250,"price":67.81,"value":84762.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."}],"balance_after":104245,"source":{"system":"sec-edgar","filing":"0001567619-20-013577","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013577/doc1.xml","form_type":"4"}},{"id":3082880,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-07-16T01:32:23.000Z","date":"2020-07-13","kind":"exercise","acquired":false,"shares":8977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":49423,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":8977},"source":{"system":"sec-edgar","filing":"0001567619-20-013325","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013325/doc1.xml","form_type":"4"}},{"id":3082879,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-07-16T01:32:23.000Z","date":"2020-07-13","kind":"exercise","acquired":false,"shares":13810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":75716,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":13810},"source":{"system":"sec-edgar","filing":"0001567619-20-013325","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013325/doc1.xml","form_type":"4"}},{"id":3082878,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-07-16T01:32:23.000Z","date":"2020-07-13","kind":"exercise","acquired":false,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":1250,"derivative":{"exercise_price":67.81,"exercise_date":"2017-01-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001567619-20-013325","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013325/doc1.xml","form_type":"4"}},{"id":3082877,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-16T01:32:23.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":23011,"price":130,"value":2991430.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price.  The price actually received ranged from $130.00 to $130.025.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":102995,"source":{"system":"sec-edgar","filing":"0001567619-20-013325","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013325/doc1.xml","form_type":"4"}},{"id":3082876,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-16T01:32:23.000Z","date":"2020-07-13","kind":"exercise","acquired":true,"shares":8977,"price":63.1,"value":566448.7,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."}],"balance_after":126006,"source":{"system":"sec-edgar","filing":"0001567619-20-013325","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013325/doc1.xml","form_type":"4"}},{"id":3082875,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-16T01:32:23.000Z","date":"2020-07-13","kind":"exercise","acquired":true,"shares":13810,"price":67.81,"value":936456.1,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."}],"balance_after":117029,"source":{"system":"sec-edgar","filing":"0001567619-20-013325","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013325/doc1.xml","form_type":"4"}},{"id":3082874,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-16T01:32:23.000Z","date":"2020-07-13","kind":"exercise","acquired":true,"shares":224,"price":67.81,"value":15189.44,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."}],"balance_after":103219,"source":{"system":"sec-edgar","filing":"0001567619-20-013325","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013325/doc1.xml","form_type":"4"}},{"id":3082873,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-07-16T01:32:23.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":339,"price":62.586,"value":21216.654,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":102995,"source":{"system":"sec-edgar","filing":"0001567619-20-013325","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920013325/doc1.xml","form_type":"4"}},{"id":3168431,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-04-28T18:37:44.000Z","date":"2020-04-24","kind":"sale","acquired":false,"shares":2680,"price":97.3184,"value":260813.312,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in column 4 is the weighted average price.  The price actually received ranged from $97.17 to $97.50.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":102656,"source":{"system":"sec-edgar","filing":"0001567619-20-008539","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920008539/doc1.xml","form_type":"4"}},{"id":3168430,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-04-28T18:37:44.000Z","date":"2020-04-24","kind":"sale","acquired":false,"shares":3678,"price":96.8492,"value":356211.3576,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price.  The price actually received ranged from $96.17 to $97.15.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":105336,"source":{"system":"sec-edgar","filing":"0001567619-20-008539","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920008539/doc1.xml","form_type":"4"}},{"id":3168429,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-04-28T18:37:44.000Z","date":"2020-04-24","kind":"sale","acquired":false,"shares":13642,"price":95.3374,"value":1300592.8108,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price.  The price actually received ranged from $95.015 to $95.99.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":109014,"source":{"system":"sec-edgar","filing":"0001567619-20-008539","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920008539/doc1.xml","form_type":"4"}},{"id":3171928,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-04-22T21:15:05.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":17213,"price":90,"value":1549170.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 11, 2020."}],"balance_after":122656,"source":{"system":"sec-edgar","filing":"0001567619-20-008272","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920008272/doc1.xml","form_type":"4"}},{"id":3196812,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-03-25T00:48:16.000Z","date":"2020-03-20","kind":"tax_withholding","acquired":false,"shares":5836,"price":73.05,"value":426319.8,"ownership":{"direct":true},"balance_after":139869,"source":{"system":"sec-edgar","filing":"0001567619-20-006968","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006968/doc1.xml","form_type":"4"}},{"id":3206289,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-03-18T01:15:03.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":51970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter."}],"balance_after":51970,"derivative":{"exercise_price":73.82,"exercise_date":"2021-03-16","expiration_date":"2030-03-15","underlying":"Common Stock","underlying_shares":51970},"source":{"system":"sec-edgar","filing":"0001567619-20-006632","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006632/doc1.xml","form_type":"4"}},{"id":3206288,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-03-18T01:15:03.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":18220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 16, 2020. Price not applicable."}],"balance_after":145705,"source":{"system":"sec-edgar","filing":"0001567619-20-006632","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006632/doc1.xml","form_type":"4"}},{"id":3206287,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-03-18T01:15:03.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":10496,"price":84.5,"value":886912.0,"ownership":{"direct":true},"balance_after":127485,"source":{"system":"sec-edgar","filing":"0001567619-20-006632","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006632/doc1.xml","form_type":"4"}},{"id":3228476,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2020-03-05T02:51:37.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":13136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2019 as set forth in the Issuer's audited financial statements."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2020, 2021 and 2022, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events."}],"balance_after":137981,"source":{"system":"sec-edgar","filing":"0001567619-20-005681","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920005681/doc1.xml","form_type":"4"}},{"id":3316076,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2020-01-07T20:28:35.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":4000,"derivative":{"exercise_price":113.2,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001214659-20-000193","document":"marketforms-47235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920000193/marketforms-47235.xml","form_type":"4"}},{"id":3316075,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T20:28:35.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 100% on the anniversary of the grant date."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001214659-20-000193","document":"marketforms-47235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197355/000121465920000193/marketforms-47235.xml","form_type":"4"}},{"id":3371686,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:47:22.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":6583,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $19,197 and 314 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019. Pursuant to the applicable option award agreement, 100% of the unvested options held by the Reporting Person became fully vested following the change in control of the Issuer effected by the Merger."}],"balance_after":0,"derivative":{"exercise_price":52.41,"exercise_date":"2020-06-14","expiration_date":"2029-06-14","underlying":"Common Stock","underlying_shares":6583},"source":{"system":"sec-edgar","filing":"0001209191-19-056644","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056644/doc4.xml","form_type":"4"}},{"id":3371685,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:47:22.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $62,196 and 1,018 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":51.72,"exercise_date":"2019-06-07","expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-056644","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056644/doc4.xml","form_type":"4"}},{"id":3371684,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:47:22.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $145,268 and 2,379 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":31.53,"exercise_date":"2018-06-16","expiration_date":"2027-06-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-056644","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056644/doc4.xml","form_type":"4"}},{"id":3371683,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:47:22.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $167,281 and 2,739 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":26.18,"exercise_date":"2017-06-10","expiration_date":"2026-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-056644","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056644/doc4.xml","form_type":"4"}},{"id":3371682,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-11-14T21:47:22.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $167,981 and 2,751 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":26.01,"exercise_date":"2016-06-12","expiration_date":"2026-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-056644","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056644/doc4.xml","form_type":"4"}},{"id":3371681,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T21:47:22.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":955,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of in connection with the Merger, whereby such Issuer restricted stock unit award, whether or not vested, was cancelled in exchange for a cash payment of $26,277 and 430 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056644/doc4.xml","form_type":"4"}},{"id":3371680,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T21:47:22.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":6878,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of in connection with the acquisition of Issuer (the \"Merger\") by Exact Sciences Corporation (\"Exact Sciences\") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the \"Merger Agreement\"), among Exact Sciences, Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $189,150 and 3,098 shares of Exact Sciences common stock, having a market value of $79.95 per share, based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":955,"source":{"system":"sec-edgar","filing":"0001209191-19-056644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056644/doc4.xml","form_type":"4"}},{"id":3398891,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-03T20:05:24.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":185,"price":67.28,"value":12446.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 955 restricted stock units (RSUs) awarded on June 14, 2019 which vest in full on the first anniversary date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the RSUs become fully vested in the event of a change in control of the Company."}],"balance_after":7833,"source":{"system":"sec-edgar","filing":"0001209191-19-052461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119052461/doc4.xml","form_type":"4"}},{"id":3468683,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-03T17:49:24.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":212,"price":58.86,"value":12478.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 955 restricted stock units (RSUs) awarded on June 14, 2019 which vest in full on the first anniversary date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the RSUs become fully vested in the event of a change in control of the Company."}],"balance_after":7648,"source":{"system":"sec-edgar","filing":"0001209191-19-041247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119041247/doc4.xml","form_type":"4"}},{"id":3486469,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-18T17:57:51.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":6583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the options become fully vested in the event of a change in control of the Company."}],"balance_after":6583,"derivative":{"exercise_price":52.41,"exercise_date":"2020-06-14","expiration_date":"2029-06-14","underlying":"Common Stock","underlying_shares":6583},"source":{"system":"sec-edgar","filing":"0001209191-19-037781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119037781/doc4.xml","form_type":"4"}},{"id":3486468,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-18T17:57:51.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (RSUs) awarded on June 14, 2019 which vest in full on the first anniversary date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the RSUs become fully vested in the event of a change in control of the Company."}],"balance_after":7436,"source":{"system":"sec-edgar","filing":"0001209191-19-037781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119037781/doc4.xml","form_type":"4"}},{"id":3497529,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Worldwide R&D"}}],"security":"Common Stock","published_at":"2019-06-07T22:52:51.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":309,"price":68.782,"value":21253.638,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2019 pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":124845,"source":{"system":"sec-edgar","filing":"0001567619-19-013095","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919013095/doc1.xml","form_type":"4"}},{"id":3565779,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":87493,"kind":"person","name":"FUCHS HENRY J","position":1,"cik":"0001197355","reported_name":"FUCHS HENRY J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T18:01:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":149,"price":66.84,"value":9959.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested."}],"balance_after":6481,"source":{"system":"sec-edgar","filing":"0001209191-19-023406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119023406/doc4.xml","form_type":"4"}}],"next_cursor":"2019-04-03T18:01:50.000000Z,3565779"}